Table 4 Ablation study
Model | Dataset | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BC4CHEMD | BC2GM | BC5CDR-Disease | BC5CDR-Chem | NCBI-Disease | |||||||||||
P | R | F1 | P | R | F1 | P | R | F1 | P | R | F1 | P | R | F1 | |
Baseline | 91.07 | 93.80 | 92.42 | 86.27 | 83.57 | 84.90 | 85.87 | 88.45 | 87.14 | 94.51 | 93.70 | 93.61 | 88.81 | 90.10 | 89.45 |
PAMDFGA w/o \(Loss_{o}\) | 92.56 | 92.67 | 92.62 | 85.13 | 84.79 | 84.96 | 86.47 | 87.97 | 87.22 | 93.31 | 94.30 | 93.80 | 88.29 | 91.15 | 89.70 |
PAMDFGA w/o \(Loss_{p}\) | 92.19 | 92.13 | 92.16 | 85.63 | 84.89 | 85.26 | 86.63 | 88.31 | 87.46 | 93.64 | 94.56 | 94.10 | 89.02 | 91.25 | 90.12 |
PAMDFGA | 91.74 | 93.37 | 92.55 | 85.43 | 85.47 | 85.45 | 87.11 | 87.95 | 87.53 | 93.66 | 94.67 | 94.16 | 89.76 | 91.35 | 90.55 |